Melanie Pley-Bouvin
Tours, 37032, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Anti-V1/V3-glycan broadly HIV-1 neutralizing antibodies in a post-treatment controller.
Journal: Cell host & microbe
Published: January 30, 2023
Epitope convergence of broadly HIV-1 neutralizing IgA and IgG antibody lineages in a viremic controller.
Journal: The Journal of experimental medicine
Published: October 01, 2021
Escape of HIV-1 envelope glycoprotein from the restriction of infection by IFITM3.
Journal: Journal of virology
Published: December 10, 2020
Differential utilization of CD4+ by transmitted/founder and chronic envelope glycoproteins in a MSM HIV-1 subtype B transmission cluster.
Journal: AIDS (London, England)
Published: September 15, 2020
Impact of HIV-1 Diversity on Its Sensitivity to Neutralization.
Journal: Vaccines
Published: July 06, 2019
Sensitivity to Broadly Neutralizing Antibodies of Recently Transmitted HIV-1 Clade CRF02_AG Viruses with a Focus on Evolution over Time.
Journal: Journal of virology
Published: August 28, 2018
Evolution of the Envelope Glycoprotein of HIV-1 Clade B toward Higher Infectious Properties over the Course of the Epidemic.
Journal: Journal of virology
Published: July 11, 2018
Phenotypic properties of envelope glycoproteins of transmitted HIV-1 variants from patients belonging to transmission chains.
Journal: AIDS (London, England)
Published: June 22, 2018
V1/V2 Neutralizing Epitope is Conserved in Divergent Non-M Groups of HIV-1.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: September 29, 2015
Drift of the HIV-1 envelope glycoprotein gp120 toward increased neutralization resistance over the course of the epidemic: a comprehensive study using the most potent and broadly neutralizing monoclonal antibodies.
Journal: Journal of virology
Published: September 19, 2014
Last Updated: 09/26/2026